1. Home
  2. GANX vs DSY Comparison

GANX vs DSY Comparison

Compare GANX & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • DSY
  • Stock Information
  • Founded
  • GANX 2017
  • DSY 2020
  • Country
  • GANX United States
  • DSY China
  • Employees
  • GANX N/A
  • DSY N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • DSY
  • Sector
  • GANX Health Care
  • DSY
  • Exchange
  • GANX Nasdaq
  • DSY Nasdaq
  • Market Cap
  • GANX 79.8M
  • DSY 85.8M
  • IPO Year
  • GANX 2021
  • DSY N/A
  • Fundamental
  • Price
  • GANX $1.76
  • DSY $0.61
  • Analyst Decision
  • GANX Strong Buy
  • DSY
  • Analyst Count
  • GANX 6
  • DSY 0
  • Target Price
  • GANX $8.00
  • DSY N/A
  • AVG Volume (30 Days)
  • GANX 901.0K
  • DSY 294.2K
  • Earning Date
  • GANX 11-12-2025
  • DSY 01-01-0001
  • Dividend Yield
  • GANX N/A
  • DSY N/A
  • EPS Growth
  • GANX N/A
  • DSY 120.37
  • EPS
  • GANX N/A
  • DSY 0.01
  • Revenue
  • GANX N/A
  • DSY $7,323,356.00
  • Revenue This Year
  • GANX N/A
  • DSY N/A
  • Revenue Next Year
  • GANX N/A
  • DSY N/A
  • P/E Ratio
  • GANX N/A
  • DSY $49.50
  • Revenue Growth
  • GANX N/A
  • DSY 16.37
  • 52 Week Low
  • GANX $1.41
  • DSY $0.58
  • 52 Week High
  • GANX $2.81
  • DSY $7.33
  • Technical
  • Relative Strength Index (RSI)
  • GANX 43.08
  • DSY 28.71
  • Support Level
  • GANX $1.74
  • DSY $0.60
  • Resistance Level
  • GANX $2.08
  • DSY $0.79
  • Average True Range (ATR)
  • GANX 0.15
  • DSY 0.06
  • MACD
  • GANX -0.03
  • DSY 0.00
  • Stochastic Oscillator
  • GANX 5.26
  • DSY 11.96

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

Share on Social Networks: